These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 7638372

  • 21. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 23. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A, Hall I, Spelman R.
    Ann Allergy Asthma Immunol; 2001 May 29; 86(5):575-82. PubMed ID: 11379810
    [Abstract] [Full Text] [Related]

  • 25. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U, Price D, Howes T, Sussman G.
    J Asthma; 2008 Apr 29; 45(3):215-20. PubMed ID: 18415829
    [Abstract] [Full Text] [Related]

  • 26. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 29; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 27. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma.
    Roux C, Kolta S, Desfougères JL, Minini P, Bidat E.
    Pediatrics; 2003 Jun 29; 111(6 Pt 1):e706-13. PubMed ID: 12777589
    [Abstract] [Full Text] [Related]

  • 28. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
    Nathan RA, Bleecker ER, Kalberg C, Fluticasone Propionate Study Group.
    Am J Med; 2001 Aug 15; 111(3):195-202. PubMed ID: 11530030
    [Abstract] [Full Text] [Related]

  • 29. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.
    Bleecker ER, Welch MJ, Weinstein SF, Kalberg C, Johnson M, Edwards L, Rickard KA.
    J Allergy Clin Immunol; 2000 Jun 15; 105(6 Pt 1):1123-9. PubMed ID: 10856145
    [Abstract] [Full Text] [Related]

  • 30. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Lin J, Kang J, Lee SH, Wang C, Zhou X, Crawford J, Jacques L, Stone S.
    Respir Med; 2015 Jan 15; 109(1):44-53. PubMed ID: 25524507
    [Abstract] [Full Text] [Related]

  • 31. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
    Creticos P, Knobil K, Edwards LD, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Apr 15; 88(4):401-9. PubMed ID: 11991558
    [Abstract] [Full Text] [Related]

  • 32. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 15; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 33. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 15; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 34. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 15; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S, Engelstätter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J.
    Pulm Pharmacol Ther; 2009 Jun 15; 22(3):214-20. PubMed ID: 19141327
    [Abstract] [Full Text] [Related]

  • 36. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug 15; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 37. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM.
    J Allergy Clin Immunol; 1999 Feb 15; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma.
    Vaessen-Verberne AA, van den Berg NJ, van Nierop JC, Brackel HJ, Gerrits GP, Hop WC, Duiverman EJ, COMBO Study Group.
    Am J Respir Crit Care Med; 2010 Nov 15; 182(10):1221-7. PubMed ID: 20622031
    [Abstract] [Full Text] [Related]

  • 39. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
    Dahl R, Lundback B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, Barnacle H.
    Chest; 1993 Nov 15; 104(5):1352-8. PubMed ID: 8222787
    [Abstract] [Full Text] [Related]

  • 40. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
    Levy ML, Stevenson C, Maslen T.
    Thorax; 1996 Nov 15; 51(11):1087-92. PubMed ID: 8958890
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.